Align Financial’s Pfizer PFE Stock Holding History

Align Financial’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.4K	Hold	514	–	–	0.01%	251
2026 Q1	$14.4K	Sell	514 -17,629	-97%	-$469K	0.01%	244
2025 Q4	$18.1M	Buy	+18,143	New	+$458K	0.01%	236

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Align Financial's PFE Position: Q2 2026 in Review

Align Financial held its Pfizer (PFE) position steady in Q2 2026 at 514 shares worth $12.4K. The position accounts for 0.01% of the portfolio, ranked #251.

Align Financial first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $18.1M in Q4 2025. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Align Financial held 514 shares of Pfizer worth $12.4K as of Q2 2026.
Align Financial left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.01% of Align Financial's portfolio in Q2 2026, its #251 holding.
Align Financial first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
Align Financial's Pfizer position peaked at $18.1M in Q4 2025.
2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Align Financial's 13F filing for Q2 2026, filed 27 Jul 2026.